154 related articles for article (PubMed ID: 11978521)
1. The role of pathologists in the quality control of diagnosis and treatment of rectal cancer-an overview.
Nagtegaal ID; van Krieken JH
Eur J Cancer; 2002 May; 38(7):964-72. PubMed ID: 11978521
[TBL] [Abstract][Full Text] [Related]
2. The circumferential margin in rectal cancer. Recommendations based on the Dutch Total Mesorectal Excision Study.
Wiggers T; van de Velde CJ
Eur J Cancer; 2002 May; 38(7):973-6. PubMed ID: 11978522
[TBL] [Abstract][Full Text] [Related]
3. [Lymph node dissection after primary surgery and neoadjuvant radiochemotherapy of rectal cancer. Interim analysis of a multicenter prospective observational study (OCUM)].
Kreis ME; Maurer CA; Ruppert R; Ptok H; Strassburg J; Junginger T; Merkel S; Hermanek P
Chirurg; 2015 Dec; 86(12):1132-7. PubMed ID: 26223668
[TBL] [Abstract][Full Text] [Related]
4. The role of the pathologist in rectal cancer diagnosis and staging and surgical quality assessment.
Faus C; Roda D; Frasson M; Roselló S; García-Granero E; Flor-Lorente B; Navarro S
Clin Transl Oncol; 2010 May; 12(5):339-45. PubMed ID: 20466618
[TBL] [Abstract][Full Text] [Related]
5. Can pathological reports of rectal cancer provide national quality indicators?
Keane C; Lin AY; Kramer N; Bissett I
ANZ J Surg; 2018 Sep; 88(9):E639-E643. PubMed ID: 29569820
[TBL] [Abstract][Full Text] [Related]
6. The quality of pathological reports of postoperative specimens in rectal cancer: an audit from the Mazovia region.
Olszyna-Serementa M; Kołodziejczyk M; Sprawka A; Nasierowska-Guttmejer A; Bujko K
Pol J Pathol; 2009; 60(3):130-3. PubMed ID: 20069506
[TBL] [Abstract][Full Text] [Related]
7. Rectal cancer and the pathologist.
Berho M; Bejarano PA
Minerva Chir; 2018 Dec; 73(6):534-547. PubMed ID: 29658680
[TBL] [Abstract][Full Text] [Related]
8. The total mesorectal excision specimen for rectal cancer: a review of its pathological assessment.
Parfitt JR; Driman DK
J Clin Pathol; 2007 Aug; 60(8):849-55. PubMed ID: 17046842
[TBL] [Abstract][Full Text] [Related]
9. Product analysis and initial reliability testing of the total mesorectal excision-quality assessment instrument.
Simunovic MR; DeNardi FG; Coates AJ; Szalay DA; Eva KW
Ann Surg Oncol; 2014 Jul; 21(7):2274-9. PubMed ID: 24590437
[TBL] [Abstract][Full Text] [Related]
10. [Parametric monitoring of the quality of total mesorectal excision and surgical treatment of rectal carcinoma results of a multicenter study].
Hoch J; Ferko A; Bláha M; Ryška A; Čapov I; Dušek L; Feit J; Grega M; Hermanová M; Hovorková E; Chmelová R; Kala Z; Klos D; Kodet R; Langer D; Hadži-Nikolov D; Örhalmi J; Páral J; Tichý M; Tučková I; Vjaclovský M; Vlček P
Rozhl Chir; 2016; 95(7):262-71. PubMed ID: 27523174
[TBL] [Abstract][Full Text] [Related]
11. [Lymph node metastases in ypT1/2 rectal cancer after neoadjuvant chemoradiotherapy : The Achilles heel of organ-preserving operative procedures?].
Sprenger T; Rothe H; Beissbarth T; Conradi LC; Kauffels A; Homayounfar K; Behnes CL; Rödel C; Liersch T; Ghadimi M
Chirurg; 2016 Jul; 87(7):593-601. PubMed ID: 27106241
[TBL] [Abstract][Full Text] [Related]
12. Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis.
Lopez-Beltran A; Bassi P; Pavone-Macaluso M; Montironi R
Eur Urol; 2004 Mar; 45(3):257-66. PubMed ID: 15036668
[TBL] [Abstract][Full Text] [Related]
13. [A single center retrospective study on surgical efficacy of T3NxM0 middle-low rectal cancer without neoadjuvant therapy].
Liu P; Lou Z; Mei Z; Gao X; Hao L; Liu L; Gong H; Meng R; Yu E; Wang H; Wang H; Zhang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):66-72. PubMed ID: 30703796
[TBL] [Abstract][Full Text] [Related]
14. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control.
Nagtegaal ID; van de Velde CJ; van der Worp E; Kapiteijn E; Quirke P; van Krieken JH;
J Clin Oncol; 2002 Apr; 20(7):1729-34. PubMed ID: 11919228
[TBL] [Abstract][Full Text] [Related]
15. Cancer of the upper rectum.
Bondeven P
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697137
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of Laparoscopic Total Mesorectal Excision with Extended Lateral Pelvic Lymph Node Dissection for Advanced Lower Rectal Cancer after Preoperative Chemoradiotherapy.
Ogura A; Akiyoshi T; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M; Kuroyanagi H
World J Surg; 2017 Mar; 41(3):868-875. PubMed ID: 27730352
[TBL] [Abstract][Full Text] [Related]
17. Pathological quality assurance in gastro-intestinal cancer.
van Krieken JH; Nagtegaal ID
Eur J Surg Oncol; 2005 Aug; 31(6):675-80. PubMed ID: 15908166
[TBL] [Abstract][Full Text] [Related]
18. Individualizing surgical treatment based on tumour response following neoadjuvant therapy in T4 primary rectal cancer.
Denost Q; Kontovounisios C; Rasheed S; Chevalier R; Brasio R; Capdepont M; Rullier E; Tekkis PP
Eur J Surg Oncol; 2017 Jan; 43(1):92-99. PubMed ID: 27717529
[TBL] [Abstract][Full Text] [Related]
19. Need for objective and reproducible criteria in histopathological assessment of total mesorectal excision specimens: lessons from a national improvement project.
Demetter P; Vandendael T; Sempoux C; Ectors N; Cuvelier CA; Nagy N; Hoorens A; Jouret-Mourin A;
Colorectal Dis; 2013 Nov; 15(11):1351-8. PubMed ID: 23865820
[TBL] [Abstract][Full Text] [Related]
20. Role of total mesorectal excision and of circumferential resection margin in local recurrence and survival of patients with rectal carcinoma.
Tzardi M
Dig Dis; 2007; 25(1):51-5. PubMed ID: 17384508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
